Philips Introduces New 200mm and 150mm Stellarex 0.035” Low-dose Drug-coated Balloons to Broaden Treatment Options for Peripheral Artery Disease Patients
Amsterdam, the Netherlands, Oct. 15 (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced two new balloons to its Stellarex 0.035” low-dose drug-coated balloon (DCB) portfolio. The new 200mm and 150mm Stellarex 0.035” low-dose DCBs have received approval from the U.S. Food and Drug Administration (FDA) for the treatment of [...]









